Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleResearch Article

Analysis of the Indicence and Survival of Female Breast Cancer Patients in Beijing Over a 20-Year Period

Qijun Wang, Weixing Zhu, Xiumei Xing and Chenxu Qu
Chinese Journal of Clinical Oncology December 2006, 3 (6) 433-436;
Qijun Wang
Department of Epidemiology, Beijing Institute for Cancer Research, School of Clinical Oncology, Peking University, Beijing 100036, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Weixing Zhu
Department of Epidemiology, Beijing Institute for Cancer Research, School of Clinical Oncology, Peking University, Beijing 100036, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiumei Xing
Department of Epidemiology, Beijing Institute for Cancer Research, School of Clinical Oncology, Peking University, Beijing 100036, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chenxu Qu
Department of Epidemiology, Beijing Institute for Cancer Research, School of Clinical Oncology, Peking University, Beijing 100036, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

OBJECTIVE To provide evidence for breast cancer prevention and control through epidemiological analysis of the incidence, mortality and survival rate of female breast cancer patients in Beijing.

METHODS The female registration data in the Beijing urban area from 1982 to 2001 were retrospectively reviewed. The incidence, mortality and survival rate of female breast cancer patients were analyzed using routine and life-table statistical methods.

RESULTS During the period of 1982 to 2001, there was a trend of an average annual increase of female breast cancer incidence of 4.6% in urban Beijing, and of 4.9% in the world-population standardized incidence. The epidemiological features of urban Beijing female breast cancer showed: (1)The incidence distribution of different age groups from 25 to 80 years elevated with two peaks at ages of 45 ~ and 70~ years; (2)There was an elevation in each age group over the last 20 years; (3)The incidence rate at ages of 35 to 64 reached 95.3/106, causing breast cancer to become the number one cancer in females. The changes in the survival rate showed the following: the 5-year observed survival rate (OSR) increased from 62.0% in 1982-1983 to 68.7% in 1987~1988, and the relative-survival rate (RSR) increased from 66.3% to 74.2%. The 10-year OSR and RSR in 1987~1988 were 60.3% and 65.1%, and at 15 years 57.5% and 61.3%, respectively. The mortality rate of breast cancer patients fluctuated from 8 to 10 per 105 population over the 20 years of study.

CONCLUSION There is a trend of an annual increase in female breast cancer in Beijing. The 5-year survival is being improved gradually while the mortality remains stable. The results demonstrate that the principles of "early prevention, diagnosis and treatment" for breast cancer are effective in Beijing.

KEYWORDS:

keywords

  • breast neoplasms
  • incidence
  • mortality
  • survival rate

About 30-years of information concerning cancer morbidity and mortality has been collected by the Cancer Registration Office of Beijing since its establishment in 1976. The information suggested that lung cancer and female breast cancer (FBC) are relatively serious hazards for residents of Beijing. Lung cancer accounted for 21.7% of all malignant neoplasms and breast cancer accounted for 21.9% of cancer cases among females. Therefore, these two kinds of cancer should receive more attention. In this report, we present the epidemiological descriptive results concerning morbidity, mortality and survival of FBC patients with the goal of providing evidence for prevention and control of FBC in Beijing.

Materials and Methods

Materials

The Beijing Cancer Registration Office provided data of FBC morbidity and death from four districts (Dongcheng, Xicheng, Xuanwu, Chongwen) from 1982 to 2001. The Statistical Bureau of Beijing provided corresponding data for the four district population.

Quality control

A follow-up has been conducted for the 2.36 million residents in the four districts to verify and complete the records. Two sample surveys were completed in 1984 and 1992 to evaluate the completeness and accuracy of the cancer reporting system and completeness was found to be 92.4%.[1, 2] Among these cancer reports, the final diagnosis for 71.4% of the cases was made on pathological or cytological evidence, 28.1% on X-ray, ultrasonic or biochemical examinations and 0.5% on clinical symptoms.[3]

Follow-up

A two-stage follow-up was completed. From 1982 to 1987, we follow-up-visited 491 FBC cases among 7,284 cancer morbidity cases diagnosed from January 1 1982 to December 30, 1983. The second-stage follow-up was conducted from 1987 to 2002 among 661 FBC cases screened from 7,897 cancer cases, who were diagnosed from June 1,1987 to December 30,1988.

Statistical methods

FBC corresponds to codes 174 in ICD-9 and C50 in ICD-10. We tabulated the incidence, standardized incidence, and truncated-age incidence rate at 35 ~64 years of age, mortality and standardized mortality by years, gender and age group. Observed-survival rate (OSR) at 5 years, relative-survival rate (RSR),[4] 10 and 15-year survival rates were analyzed by life tables.

Results

Hazard of FBC in the Beijing urban area

Morbidity of FBC and its sequence lists

From 1982 to 2001, 7,350 FBC cases were reported in the four districts of Beijing. In 1982, FBC (n=234) accounted for 14.4% of all female malignant neoplasms (n=1621). Following lung cancer, FBC was the 2nd most common neoplasm among females. However in 2001, 578 FBC cases accounted for 21.9% of all female malignant neoplasms (n=2,635) and FBC had became the most common female neoplasm.

Incidence and mortality of FBC

Table 1. shows the incidence and mortality of FBC in Beijing from 1982 to 2001. There was an increase of 91.0% over the 20 years and an annual rate of increase of 4.6%. If the annual FBC incidence was standardized by the world population to exclude an aging factor, the incidence rate increased from 18.7/105 to 37.1/105. The increasing rate in the standardized incidence was 98.4% over the 20 year period with an annual increase of 4.9%. Therefore, the elevation in the FBC incidence among females of Beijing was significant. However, the FBC mortality remained relatively stable, fluctuating from 8/105 to 10/105, showing that the patients suffering from FBC can expect an relatively optimistic life span.

View this table:
  • View inline
  • View popup
Table 1.

Incidence and mortality of FBC patients patients in Beijing, 1982~2001(1/105)

Epidemiology of female breast cancer in Beijing

Age distribution of FBC cases

Two-noticeable peaks in the elevation of FBC incidence were found during 1982 and 1983. The incidence of FBC started to increase quickly at an age of 35 years with the first peak developing at an age of 50 years (59.4/105). Then, a little decrease was observed after 55 years of age until the second noticeable peak occurred at 65 years of age (57.3/105). Then the incidence decreased with residents older than 80 years showing an incidence of 38.7/105. The pattern of age distribution of FBC from 1991 to 1992 was similar to that of 1982 ~1983 but the incidence slightly increased in every age group. However, the nature of the age distribution in 2000~2001 was quite different. Besides an increase of incidence in every age group, the two peaks in the distribution were very obvious (Table 2). In addition, the first peak moved to an earlier age group (5 years). The peak value occurred in the age group of 45~ and reached a level of 189.6/105, i.e. 2.2 times greater than that at 1982 ~1983. The second peak occurred in a delayed age group (5 yeas) near the age of 70-years. The peak value was 108.9/105, 1.9 times ofthat of 1982-1983.

View this table:
  • View inline
  • View popup
Table 2.

Age specified incidence of breast cancer patients in Beijing

Truncated age-adjusted rate of FBC

The truncated age-adjusted rate is often used in descriptive epidemiology to illustrate the hazards of malignant neoplasms to the health of economically productive population. It is also a indirect index of hazards to economics. From 1982 to 2001, the truncated age adjusted rate of FBC doubled (increased from 45.8/105 to 95.3/105).

Survival rate of FBC patients

When compared with other common malignant neoplasms, the survival rate of FBC cases was relatively optimistic. During 1982 ~1983 and 1987~1988, the FBC victims were found to have a 5~year relative survival rate of approximately 70% while the value for lung cancer patients was only 10%. The 5~year OSR for FBC cases was 62.0% during 1982~1983 and the RSR 66.3%. However during 1987 and 1988 the OSR increased to 68.7% and the RSR reached 74.2% (Table 3). The 10~year OSR and 10~year RSR of FBC were 60.3% and 65.1% respectively at the same time, similar to 15~year OSR and 15~year RSR (OSR=57.7% and RSR=61.3). These results suggested that the long-term prognosis of 5-year survivors was favourable.

View this table:
  • View inline
  • View popup
Table 3.

The survival rate of patients with some common neoplasms in Beijing

Discussion

Most developed countries, which have a high FBC incidence, have maintained a stable incidence since the 1990’s,[5] while some developing countries, such as China, have experienced a rising incidence,[6,7] thus attracting a great deal of attention. Our research results have shown that there was an annual increase in the FBC incidence in Beijing of 4.6% from 1982 to 2001, surpassing the international average increase of 2%. Although the FBC incidence reached 40.1/105 during 2000 and 2001, the mortality of the FBC cases remained relatively stable fluctuating between 8/105 and 10/105.

The 5-year RSR is often used internationally to evaluate the hazards of neoplasms to social health. The 5-year RSR for FBC patients was 66.3% in Beijing during 1982 and 1983 followed by an increase to 74.2% during 1987 and 1988. This enhanced RSR indicated that the degree of healing rate and life span of FBC patients had been improved. The improvements have resulted from a better FBC census, early diagnosis and treatment,[8] and introduction of new medical technology.

The alternation of the two peaks in the age distribution of FBC cases suggested that the risk or exposure to factors resulting in FBC had changed. Socioeconomic development, alternation in life style, changes in eating habits and augmentation of metal stress[9, 10] may have been influential. The results of this research may be useful for further FBC epidemiological studies to seek prevention and cures for FBC.

The truncated age-adjusted rate of FBC had greatly increased over the 20 year period of our study, reaching 95.3/105 in 2001, and becoming the most common cancer among females. This disease strongly impairs working females between 35 and 64 of age, but also is a detriment on society, economics, family and mental health. Therefore, it is imperative that the risk factors be identified through research so that this increase in FBC may be prevented in the future.

  • Received September 14, 2006.
  • Accepted December 10, 2006.
  • Copyright © 2006 by Tianjin Medical University Cancer Institute & Hospital and Springer

References

  1. ↵
    1. Wang QJ,
    2. Zhou JJ,
    3. Gao F, et al
    . Evaluation on the quality of the data of mortality statistics in Beijing Cancer Registration, Chin J Heal Stat? 1988;5:5–7 (Chinese).
    OpenUrl
  2. ↵
    1. Wang QJ,
    2. Zhu WX,
    3. Xing XM, et al
    . The investigation and analysis of missing report rate on cancer registration of Beijing. Journal of Practical Oncology. 1993;7:1–4 (Chinese).
    OpenUrl
  3. ↵
    1. Li LD,
    2. Rong KQ,
    3. Li FZ, et al
    . Morbidity and death of cancer in some Chinese pilot city (. 1 st Ed) China Medicinal Science & Technoligy Publishing House. 2001;19.
  4. ↵
    1. Wang QJ,
    2. Zhu WX,
    3. Li L
    . Cancer survival in urban Beijing. J Chin Cancer. 2001;10:263–264 (Chinese).
    OpenUrl
  5. ↵
    1. Kelsey JL,
    2. Gammon MD
    . Epidemiology of breast cancer. Epidemiol Review. 1990;12:228–240.
    OpenUrlPubMed
  6. ↵
    1. Parkin DM,
    2. Pisani P,
    3. Ferlay J
    . Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80:827–841.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Li GC,
    2. Ye Z
    . Cancer statistical report in US 1999. J Chin Cancer. 2000;9:456 (Chinese).
    OpenUrl
  8. ↵
    1. Breeders MJ,
    2. Verbeek AL
    . Breast cancer epidemiology and risk factors. J Nucl Med. 1997;41:179–188.
    OpenUrl
  9. ↵
    1. Kelsey JL
    . Breast cancer epidemiology: summary and future directions. Epidemiol Review. 1993;15:256–263.
    OpenUrlPubMed
  10. ↵
    1. Vutuc C,
    2. Haidinger G
    . Epidemiology and prevention of breast cancer. Wien Med Wochenschr. 2000;150:54–57.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 3 (6)
Chinese Journal of Clinical Oncology
Vol. 3, Issue 6
1 Dec 2006
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of the Indicence and Survival of Female Breast Cancer Patients in Beijing Over a 20-Year Period
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Analysis of the Indicence and Survival of Female Breast Cancer Patients in Beijing Over a 20-Year Period
Qijun Wang, Weixing Zhu, Xiumei Xing, Chenxu Qu
Chinese Journal of Clinical Oncology Dec 2006, 3 (6) 433-436;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Analysis of the Indicence and Survival of Female Breast Cancer Patients in Beijing Over a 20-Year Period
Qijun Wang, Weixing Zhu, Xiumei Xing, Chenxu Qu
Chinese Journal of Clinical Oncology Dec 2006, 3 (6) 433-436;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Survival rate of FBC patients
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Multi-Targeted Therapies in Non-Small Cell Lung Cancer
  • Radiotherapy in Non-Functioning Pituitary Macroadenoma: Mansoura Experience
  • Expression of the B-Cell Lymphoma/Leukemia 11A Gene in Malignant Hematological Cell Lines through Quantitative Reverse Transcription Polymerase Chain Reaction
Show more Research Article

Similar Articles

Keywords

  • breast neoplasms
  • incidence
  • mortality
  • survival rate

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire